The annual meeting of the American Urological Association takes place May 3–6 at the Henry B. González Convention Center in San Antonio, Texas. Each year, faculty, fellow physicians, and resident physicians from the Department of Urology travel to this major event to present research and participate in discussion panels with other leading urologists from around the country.
Following is a schedule of all of this year's appearances by members of our department, beginning with presentations given at an associated event on Thursday, May 2, in San Antonio hosted by the Society for Fetal Urology.
Visit the AUA2024 meeting site to view the full program.
Thursday
Society for Fetal Urology Case Presentation Sessions
Grand Hyatt San Antonio
5:10 p.m.
Speaker: R. Grant Owens, MD
Breaking the Rules: Upper Pole Ureteropelvic Junction Obstruction Causing Massive Urinary Tract Dilation in a Neonate with Prenatal Diagnosis of Multicystic Dysplastic Kidney
5:30 p.m.
Speaker: Paige De Rosa, MD
Urethral Duplication Presenting as Scrotal Cystic Lesion
Friday
1 p.m. to 3 p.m. • 301B
Presenter: Bradley A. Erickson, MD, MS
MP12-15: Erectile Dysfunction and Stress Urinary Incontinence Rates are Higher in Veterans Electing Prostatectomy Inside of the Veterans Health Administration (VHA) Versus the Community: Analyzing Survivorship Care After CHOICE Legislation
Saturday
7 a.m. to 9 a.m. • 301B
Presenter: Annah J. Vollstedt, MD
MP23-05: Platelet-Rich Plasma Injection For The Treatment Of Stress Urinary Incontinence In Females: A Randomized Placebo-Controlled Trial
9:30 a.m. to 11:30 a.m. • 303B
Presenter: Charles H. Schlaepfer, MD
MP30-05: Comparative Analysis of Current Versus Perceived Optimized Use of Point-Of-Care Ultrasound in Urology
10:50 a.m. • 303A
Speaker: Abdul Baseet Arham, MBBS
PD25-09: Toll-Like Receptor-2 (TLR2) Underactivity is Associated with Worse Urinary Symptoms in Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
1 p.m. to 3 p.m. • 304B
Presenter: Mohamad Abou Chakra, MD
MP35-02: Impact of Positive Bladder Cancer Family History on the Prognosis of Patients with Non-Muscle Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin
1:40 p.m. • 225D
Speaker: Charles H. Schlaepfer, MD
PD31-05: Determining the Quality of a Year Living with Adult-Acquired Buried Penis Using Health-State Utilities
Sunday
7 a.m. to 9 a.m. • 302B
Presenter: Ryan L. Steinberg, MD
MP45-13: Retrospective Evaluation of Patients Undergoing KidneySeqTM Genetic Testing in the Evaluation of Nephrolithiasis and Nephrocalcinosis
7 a.m. to 9 a.m. • Video Abstract Theater
Moderator: Bradley A. Erickson, MD, MS
V10: Lower Tract Reconstruction (including Transgender) I
7 a.m. to 9 a.m. • 221C
Presenter: Charles H. Schlaepfer, MD
MP48-07: Determining Quality of Life of Obstructive Lower Urinary Tract Disease Using Health Utilities
9:30 a.m. to 11:30 a.m. • 301B
Moderator: Douglas W. Storm, MD
MP50: Pediatrics III
9:30 a.m. to 11:30 a.m. • 221C
Presenter: Paige De Rosa, MD
MP54-19: No results found: Are LGBTQ specific urologic cancer concerns represented on major medical center websites?
10:50 a.m. • 301A
Speaker: Ian McElree, MS, BS
PD41-09: Sequential Endoluminal Gemcitabine and Docetaxel Versus Bacillus Calmette–Guérin for the Treatment of High-Grade Upper Tract Urothelial Carcinoma
1 p.m. to 3 p.m. • 301B
Moderator: Christopher S. Cooper, MD
MP55: Pediatrics IV
Monday
8:25 a.m. to 8:55 a.m. • Stars at Night Ballroom
Speaker: Bradley A. Erickson, MD, MS
Crossfire: Controversies in Urology: Bulbar Urethral Stricture Substitution Urethroplasty vs Drug Coated
9:30 a.m. to 11:30 a.m. • 304B
Presenter: Christopher S. Cooper, MD
MP72-11: The Correlation Between Renal Medullary Pyramidal Thickness, Parenchymal Thickness, and Differential Renal Function in Hydronephrotic Kidneys
Presenter: Christopher S. Cooper, MD
MP72-17: The Utility of Renal Sonographic Measurements in Differentiating Children with Grades 2, 3, and 4 Hydronephrosis
9:30 a.m. to 11:30 a.m. • 302B
Presenter: Mohamad Abou Chakra, MD
MP71-16: Survey on Clinical Practice Patterns in the United States for Using Intravesical Chemotherapy in the Management of Bacillus Calmette-Guérin Unresponsive Non-Muscle Invasive Bladder Cancer
12:20 p.m. to 12:40 p.m. • Main Lobby
Speaker: Helen Yang Hougen, MD
Key Takeaways from AUA2024: Oncology: Bladder
1 p.m. to 3 p.m. • 302B
Presenter: Charles H. Schlaepfer, MD
MP75-06: Determining Quality of Life Effect on Risk Aversion on Obstructive Voiding Using Health Utilities